awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26775361-ABBF2332-480E-4F37-B283-5D320326CAF5
Q26775361-ABBF2332-480E-4F37-B283-5D320326CAF5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26775361-ABBF2332-480E-4F37-B283-5D320326CAF5
Potential role for mammalian target of rapamycin inhibitors as first-line therapy in hormone receptor-positive advanced breast cancer
P2860
Q26775361-ABBF2332-480E-4F37-B283-5D320326CAF5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26775361-ABBF2332-480E-4F37-B283-5D320326CAF5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
005dabb9cf0b9a8dba79dc6c15e2e20c281a23bc
P2860
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.